103 related articles for article (PubMed ID: 16052533)
1. A signal achievement in the treatment of arthritis.
Cron RQ
Arthritis Rheum; 2005 Aug; 52(8):2229-32. PubMed ID: 16052533
[No Abstract] [Full Text] [Related]
2. T-cell agents in the treatment of rheumatoid arthritis - 2011 update.
Solomon GE
Bull NYU Hosp Jt Dis; 2011; 69(3):230-2. PubMed ID: 22035434
[No Abstract] [Full Text] [Related]
3. Orencia approved for rheumatoid arthritis.
Health News; 2006 Mar; 12(3):2. PubMed ID: 16535763
[No Abstract] [Full Text] [Related]
4. [Abatacept in the treatment of active rheumatoid arthritis].
Nielsen H; Hansen A
Ugeskr Laeger; 2009 Jan; 171(4):214-7. PubMed ID: 19174034
[TBL] [Abstract][Full Text] [Related]
5. One more rheumatoid drug.
Health News; 2004 Jan; 10(1):8. PubMed ID: 15002381
[No Abstract] [Full Text] [Related]
6. T-cell agents in the treatment of rheumatoid arthritis - 2012 update.
Solomon GE
Bull NYU Hosp Jt Dis; 2012; 70(3):191-4. PubMed ID: 23259627
[No Abstract] [Full Text] [Related]
7. Abatacept helps people with severe RA.
Health News; 2006 Oct; 12(10):2. PubMed ID: 17165175
[No Abstract] [Full Text] [Related]
8. Rituximab and abatacept for rheumatoid arthritis.
BMJ Group
Drug Ther Bull; 2008 Aug; 46(8):57-61. PubMed ID: 18687584
[TBL] [Abstract][Full Text] [Related]
9. Abatacept therapy for rheumatoid arthritis in the setting of hepatitis C infection.
Mahajan TD; Hooker R; Maher L; Brown G; Reimold A
J Clin Rheumatol; 2010 Oct; 16(7):332-4. PubMed ID: 20859223
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocyte-associated antigen 4 Ig-induced asthma in the treatment of rheumatoid arthritis.
Bao J; Li T; Zhao J; Zhang CY
J Rheumatol; 2012 Sep; 39(9):1903. PubMed ID: 22942310
[No Abstract] [Full Text] [Related]
11. TNF-alpha antagonists and other recombinant proteins for the treatment of rheumatoid arthritis.
Brasington R
J Hand Surg Am; 2009 Feb; 34(2):349-50. PubMed ID: 19135810
[No Abstract] [Full Text] [Related]
12. Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation.
Konsta M; Rallis E; Karameris A; Stratigos A; Sfikakis PP; Iliopoulos A
J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):257-8. PubMed ID: 22280512
[No Abstract] [Full Text] [Related]
13. Is abatacept an effective treatment for patients with RA who do not respond to other anti-TNF treatments?
Taylor PC
Nat Clin Pract Rheumatol; 2006 Mar; 2(3):128-9. PubMed ID: 16932670
[No Abstract] [Full Text] [Related]
14. A nursing guide to infusion therapy with abatacept for the treatment of rheumatoid arthritis.
Barr C
J Infus Nurs; 2007; 30(2):96-104; quiz 120. PubMed ID: 17413494
[TBL] [Abstract][Full Text] [Related]
15. [Alternatives in the treatment of rheumatoid arthritis: reasons for using abatacept].
Castañeda S; Martínez Calatrava MJ; Herrero-Beaumont G
Rev Clin Esp; 2012 May; 212(5):244-54. PubMed ID: 22176928
[TBL] [Abstract][Full Text] [Related]
16. [Fusion protein abatacept. Remission in every 5th TNF-alpha refractory patient].
MMW Fortschr Med; 2008 Jun; 150(26-27):56-7. PubMed ID: 18683309
[No Abstract] [Full Text] [Related]
17. Putting new disease-modifying antirheumatic drugs into perspective.
Saseen JJ
Pharmacotherapy; 2007 Dec; 27(12):1609-10. PubMed ID: 18041880
[No Abstract] [Full Text] [Related]
18. Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists.
Scheinfeld N
J Dermatolog Treat; 2006; 17(4):229-34. PubMed ID: 16971318
[TBL] [Abstract][Full Text] [Related]
19. Use of abatacept in eosinophilic asthma.
Abdelshaeed R; Griffiths GB; Neighbour H
J Allergy Clin Immunol Pract; 2014; 2(2):220-1. PubMed ID: 24607053
[No Abstract] [Full Text] [Related]
20. Comparative overview of safety of the biologics in rheumatoid arthritis.
Khraishi M
J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
